IC

IRIS Capital Investment

Europe, Ile-de-France, France, Neuilly-sur-seine

Description

IRIS Capital Investment is an independent provider of capital to publicly-listed companies.

Investor Profile

IRIS Capital Investment has backed more than 7 startups, with 2 new investments in the last 12 months alone. The firm has led 4 rounds, about 57% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Equity, Series A, Series Unknown rounds (top funding stages).
  • Majority of deals are located in France, South Korea, Germany.
  • Strong thematic focus on Biotechnology, Pharmaceutical, Health Diagnostics.
  • Led 2 rounds in the past year.

Stage Focus

  • Post Ipo Equity (43%)
  • Series A (29%)
  • Series Unknown (14%)
  • Post Ipo Debt (14%)

Country Focus

  • France (71%)
  • South Korea (14%)
  • Germany (14%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Health Diagnostics
  • Communities
  • E-commerce
  • Sharing Economy
  • Financial Services
  • Fintech
  • Document Management
  • Law Enforcement
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does IRIS Capital Investment frequently co-invest with?

HD
Europe, Ile-de-France, France, Paris
Co-Investments: 2
Elevation Capital Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Laguna Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
D·CAMP
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
TC
North America, Pennsylvania, United States, Radnor
Co-Investments: 2
saltlux
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Hana Financial Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
BD
Europe, Ile-de-France, France, Paris
Co-Investments: 2

What are some of recent deals done by IRIS Capital Investment?

SynBiotic

München, Bayern, Germany

SynBiotic is a cannabinoid company.

BiotechnologyCannabisWellness
Post Ipo DebtApr 17, 2025
Median Technologies

Valbonne, Provence-Alpes-Cote d'Azur, France

MEDIAN Technologies develops medical imaging software and services dedicated to oncology clinical trials, screening, and clinical practice.

Clinical TrialsHealth CareOncologyPharmaceutical
Post Ipo EquityJan 24, 2025
Amount Raised: $10,481,499
Poxel

Lyon, Rhone-Alpes, France

Poxel is a research integrated pharmaceutical company that develops products for metabolic diseases.

BiotechnologyHealth DiagnosticsPharmaceutical
Post Ipo EquityMar 23, 2023
Amount Raised: $3,792,118
Poxel

Lyon, Rhone-Alpes, France

Poxel is a research integrated pharmaceutical company that develops products for metabolic diseases.

BiotechnologyHealth DiagnosticsPharmaceutical
Post Ipo EquityAug 8, 2022
Amount Raised: $6,119,015
Amicus Lex

Yongdungpo, Seoul-t'ukpyolsi, South Korea

Amicus Lex is a provider of legal and professional services.

Document ManagementLaw EnforcementLegalProfessional ServicesService Industry
Series AApr 11, 2022
Amount Raised: $2,833,572
YouScribe

Paris, Ile-de-France, France

YouScribe is a community platform for sharing and selling digital publications in France.

CommunitiesE-CommerceSharing Economy
Series UnknownFeb 11, 2022
Amount Raised: $5,675,498
Youdge

Levallois-perret, Ile-de-France, France

Youdge is a digital neo-broker with a aim to make the consumer credit market clear and accessible.

Financial ServicesFinTech
Series AOct 29, 2021
Amount Raised: $5,780,547

Find More Investors Like IRIS Capital Investment

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

IRIS Capital Investment | Pipeseed